Updated national surveillance data demonstrate increases in new cases of viral hepatitis A, B, and C driven by the opioid crisis, and racial disparities in the number of deaths.

 
 
Share this
 
 

Atlanta, GA: On September 10th, 2019 the U.S. Centers for Disease Control and Prevention (CDC) released official viral hepatitis surveillance data for the year 2017. The major takeaway from the report is that the United States experienced increases in cases of hepatitis A, hepatitis B, and hepatitis C, which were predominantly attributable to unsafe injection drug use, and lack of vaccine protection among adults at risk for hepatitis A and B infection. 

Select the file below.